Efficay of cefiderocol as salvage therapy in tricuspid endocarditis due to multidrug-resistant Acinetobacter baumannii during end-stage renal disease
Revista Española de Quimioterapia · 29.09.2026 · 39 (5) · 468
DOI: 10.37201/req/207.2026 ↗Kurz gefasst
Leserbrief in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 21.09.2026. Verfasst von Antonio Mastroianni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy. antoniomastroianni@yahoo.it. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Infectious and Tropical Diseases Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy. antoniomastroianni@yahoo.it.
- Infectious and Tropical Diseases Unit, Azienda Ospedaliera di Cosenza, Cosenza, Italy.
ORCID-Profile: Antonio Mastroianni, Sonia Greco
Zitieren
APA
Mastroianni, A., & Greco, S. (2026). Efficay of cefiderocol as salvage therapy in tricuspid endocarditis due to multidrug-resistant Acinetobacter baumannii during end-stage renal disease. Revista Española de Quimioterapia, 39(5), 468. https://doi.org/10.37201/req/207.2026
Vancouver
Mastroianni A, Greco S. Efficay of cefiderocol as salvage therapy in tricuspid endocarditis due to multidrug-resistant Acinetobacter baumannii during end-stage renal disease. Revista Española de Quimioterapia. 2026;39(5):468. doi:10.37201/req/207.2026
BibTeX
@article{Mastroianni2026,
author = {Mastroianni, Antonio and Greco, Sonia},
title = {Efficay of cefiderocol as salvage therapy in tricuspid endocarditis due to multidrug-resistant Acinetobacter baumannii during end-stage renal disease},
journal = {Revista Española de Quimioterapia},
year = {2026},
volume = {39},
number = {5},
pages = {468},
doi = {10.37201/req/207.2026}
}
EUVIMED